US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
US5169939A
(en)
|
1985-05-21 |
1992-12-08 |
Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College |
Chimeric antibodies
|
US4720449A
(en)
|
1985-06-03 |
1988-01-19 |
Polaroid Corporation |
Thermal imaging method
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
WO1991000906A1
(en)
|
1989-07-12 |
1991-01-24 |
Genetics Institute, Inc. |
Chimeric and transgenic animals capable of producing human antibodies
|
US6657103B1
(en)
|
1990-01-12 |
2003-12-02 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
DK0463151T3
(da)
|
1990-01-12 |
1996-07-01 |
Cell Genesys Inc |
Frembringelse af xenogene antistoffer
|
WO1993012227A1
(en)
|
1991-12-17 |
1993-06-24 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
DK0814159T3
(da)
|
1990-08-29 |
2005-10-24 |
Genpharm Int |
Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US7084260B1
(en)
|
1996-10-10 |
2006-08-01 |
Genpharm International, Inc. |
High affinity human antibodies and human antibodies against human antigens
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US7041871B1
(en)
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
ES2301158T3
(es)
|
1992-07-24 |
2008-06-16 |
Amgen Fremont Inc. |
Produccion de anticuerpos xenogenicos.
|
DE4228162C1
(de)
|
1992-08-25 |
1994-01-13 |
Rajewsky Klaus Dr |
Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern
|
US5565321A
(en)
|
1993-01-22 |
1996-10-15 |
Immunex Corporation |
Detection of mutations in a CD40 ligand gene
|
AU6819494A
(en)
|
1993-04-26 |
1994-11-21 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
DE4331162A1
(de)
|
1993-09-14 |
1995-03-16 |
Bayer Ag |
Verfahren zur Herstellung von Cyaninfarbstoffen
|
US7119248B1
(en)
|
1994-04-12 |
2006-10-10 |
Miltenyi Biotec Gmbh |
Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
CA2250830A1
(en)
|
1996-06-26 |
1997-12-31 |
Binhai Zheng |
Chromosomal rearrangement by insertion of two recombination substrates
|
DK0937140T3
(da)
|
1996-06-27 |
2008-01-28 |
Vlaams Interuniv Inst Biotech |
Antistofmolekyler, som interagerer specifikt med et målmolekyles aktive sted eller klöft
|
DK0942968T3
(da)
|
1996-12-03 |
2008-06-23 |
Amgen Fremont Inc |
Fuldt humane antistoffer, der binder EGFR
|
US6319906B1
(en)
|
1996-12-31 |
2001-11-20 |
Isis Pharmaceuticals |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
CA2288600C
(en)
|
1997-05-02 |
2010-06-01 |
Genentech, Inc. |
A method for making multispecific antibodies having heteromultimeric and common components
|
US20020088019A1
(en)
|
1997-09-02 |
2002-07-04 |
Oron Yacoby-Zeevi |
Methods of and pharmaceutical compositions for improving implantation of embryos
|
ATE401410T1
(de)
|
1997-11-18 |
2008-08-15 |
Pioneer Hi Bred Int |
Zusammensetzungen und verfahren für die genetische modifizierung von pflanzen
|
EP0939120A1
(en)
|
1998-02-27 |
1999-09-01 |
Gesellschaft für biotechnologische Forschung mbH (GBF) |
Method for marker-free repetitive DNA expression cassette exchange in the genome of cells or parts of cells
|
GB9823930D0
(en)
|
1998-11-03 |
1998-12-30 |
Babraham Inst |
Murine expression of human ig\ locus
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
WO2004009618A2
(en)
|
2002-07-18 |
2004-01-29 |
Crucell Holland B.V. |
Recombinant production of mixtures of antibodies
|
AU5867100A
(en)
|
1999-05-03 |
2000-12-12 |
Medarex, Inc. |
Human antibodies to staphylococcus aureus
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
US7605238B2
(en)
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
CA2307503A1
(en)
|
2000-05-02 |
2001-11-02 |
Carlos F. Barbas Iii |
Peptides for use as a vaccine or treatment for hiv infection
|
CA2416701A1
(en)
|
2000-07-21 |
2002-01-31 |
The United States Of America, As Represented By The Secretary Of Agricul Ture |
Methods for the replacement, translocation and stacking of dna in eukaryotic genomes
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
EP1343880B1
(en)
|
2000-11-17 |
2009-05-27 |
Kyowa Hakko Kirin Co., Ltd. |
Expression of xenogenous (human) immunoglobulins in cloned, transgenic bovine
|
AU2002239422B2
(en)
|
2000-11-30 |
2006-12-07 |
E. R. Squibb & Sons, L.L.C. |
Transgenic transchromosomal rodents for making human antibodies
|
EP1409646B1
(en)
|
2000-12-19 |
2012-06-13 |
Altor BioScience Corporation |
Transgenic animals comprising a humanized immune system
|
PL217921B1
(pl)
|
2001-01-05 |
2014-09-30 |
Amgen Fremont Inc |
Przeciwciało przeciw receptorowi insulinopodobnego czynnika wzrostu I, zawierająca go kompozycja farmaceutyczna, sposób jego wytwarzania, zastosowania, linia komórkowa, wyizolowana cząsteczka kwasu nukleinowego, wektor, komórka gospodarza oraz zwierzę transgeniczne
|
JP2003000243A
(ja)
|
2001-06-25 |
2003-01-07 |
Takachika Azuma |
変異体の製造法
|
FR2827302B1
(fr)
|
2001-07-13 |
2003-10-10 |
Genoway |
Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations
|
US20030108925A1
(en)
|
2001-10-05 |
2003-06-12 |
U.S. Epa |
Genetic testing for male factor infertility
|
US20060199204A1
(en)
|
2001-10-05 |
2006-09-07 |
U.S. Epa |
Genetic testing for male factor infertility
|
CA2468565C
(en)
*
|
2001-11-30 |
2014-06-03 |
Abgenix, Inc. |
Transgenic animals bearing human iglambda light chain genes
|
WO2003061363A2
(en)
|
2002-01-17 |
2003-07-31 |
Albert Einstein College Of Medicine Of Yeshiva University |
Mutations caused by activation-induced cytidine deaminase
|
US8877901B2
(en)
|
2002-12-13 |
2014-11-04 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
WO2004022738A1
(en)
|
2002-09-09 |
2004-03-18 |
California Institute Of Technology |
Methods and compositions for the generation of humanized mice
|
DE10251918A1
(de)
|
2002-11-08 |
2004-05-19 |
Horn, Carsten, Dipl.-Biochem. Dr. |
Systeme zur Erzeugung stabiler genomischer Transgen-Insertionen
|
US7700356B2
(en)
|
2002-11-08 |
2010-04-20 |
The United States Of America As Represented By The Secretary Of Agriculture |
System for gene targeting and producing stable genomic transgene insertions
|
CL2003002461A1
(es)
|
2002-11-27 |
2005-01-07 |
Dow Chemical Company Agroscien |
Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas.
|
GB2398784B
(en)
|
2003-02-26 |
2005-07-27 |
Babraham Inst |
Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
|
EP2395017A3
(en)
|
2003-05-30 |
2012-12-19 |
Merus B.V. |
Design and use of paired variable regions of specific binding molecules
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
US7205148B2
(en)
|
2003-06-11 |
2007-04-17 |
Regeneron Pharmaceuticals, Inc. |
Genome mutation by intron insertion into an embryonic stem cell genome
|
GB2403475B
(en)
|
2003-07-01 |
2008-02-06 |
Oxitec Ltd |
Stable integrands
|
US7663017B2
(en)
|
2003-07-30 |
2010-02-16 |
Institut Pasteur |
Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
|
US20050153392A1
(en)
|
2003-08-11 |
2005-07-14 |
Roland Buelow |
Transgenesis with humanized immunoglobulin loci
|
US7604994B2
(en)
|
2003-09-03 |
2009-10-20 |
Morphotek, Inc. |
Genetically altered antibody-producing cell lines with improved antibody characteristics
|
US7205140B2
(en)
|
2003-10-20 |
2007-04-17 |
Campusgen Gmbh |
Nucleotide sequence for creatinine deiminase and method of use
|
DK2383295T3
(en)
|
2003-12-10 |
2015-06-15 |
Squibb & Sons Llc |
Ip-10 antibodies and uses thereof
|
WO2005092926A2
(en)
|
2004-03-19 |
2005-10-06 |
Amgen Inc. |
Reducing the risk of human and anti-human antibodies through v gene manipulation
|
US7625549B2
(en)
|
2004-03-19 |
2009-12-01 |
Amgen Fremont Inc. |
Determining the risk of human anti-human antibodies in transgenic mice
|
KR101422286B1
(ko)
|
2004-07-22 |
2014-07-23 |
에라스무스 유니버시티 메디컬 센터 로테르담 |
결합 분자
|
FR2875239B1
(fr)
|
2004-09-10 |
2007-07-20 |
Inst Necker Ass Loi De 1901 |
Procede pour l'acceleration des mutations somatiques et son application en proteomique
|
CN101076542A
(zh)
|
2004-09-13 |
2007-11-21 |
伊沃詹尼克斯有限公司 |
特异性针对肝细胞癌和其他癌的抗体及其用途
|
WO2006044492A2
(en)
|
2004-10-14 |
2006-04-27 |
Ingenious Targeting Laboratory, Inc. |
Methods for generating rat embryo-derived cell lines and genetic modification of rat genome
|
SI1802193T1
(sl)
|
2004-10-19 |
2014-08-29 |
Regeneron Pharmaceuticals, Inc. |
Postopek za generiranje miši, homozigotne za genetsko modifikacijo
|
WO2006055704A2
(en)
|
2004-11-17 |
2006-05-26 |
Curagen Corporation |
Antibodies directed to ten-m proteins and uses thereof
|
WO2006068953A2
(en)
|
2004-12-21 |
2006-06-29 |
Astrazeneca Ab |
Antibodies directed to angiopoietin-2 and uses thereof
|
EP1874817A2
(en)
|
2005-04-29 |
2008-01-09 |
Innate Pharma |
Transgenic animals and methods of making recombinant antibodies
|
MX2007014139A
(es)
|
2005-05-14 |
2008-10-09 |
Univ Fudan |
Piggybac como una herramienta para manipulacion genetica y analisis en vertebrados.
|
EP1780272A1
(en)
|
2005-10-27 |
2007-05-02 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Method for enhancing somatic hypermutation, gene conversion and class switch recombination
|
GB0601513D0
(en)
|
2006-01-25 |
2006-03-08 |
Univ Erasmus Medical Ct |
Binding molecules 3
|
CA2638117A1
(en)
|
2006-01-25 |
2007-08-30 |
Erasmus University Medical Center Rotterdam |
Generation of heavy-chain only antibodies in transgenic animals
|
US7462759B2
(en)
|
2006-02-03 |
2008-12-09 |
Pioneer Hi-Bred International, Inc. |
Brittle stalk 2 gene family and related methods and uses
|
AU2007235496B2
(en)
|
2006-03-31 |
2013-11-21 |
E. R. Squibb & Sons, L.L.C. |
Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
|
EP2041177B1
(en)
|
2006-06-02 |
2011-12-14 |
Regeneron Pharmaceuticals, Inc. |
High affinity antibodies to human il-6 receptor
|
EP2043695B8
(en)
|
2006-06-27 |
2012-02-29 |
Sanofi Pasteur VaxDesign Corporation |
Models for vaccine assessment
|
EP1878342A1
(en)
|
2006-07-13 |
2008-01-16 |
Institut Pasteur |
Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
|
WO2008022391A1
(en)
|
2006-08-22 |
2008-02-28 |
G2 Inflammation Pty Ltd |
Method for producing antibodies
|
ES2466669T3
(es)
|
2006-10-02 |
2014-06-10 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos humanos con alta afinidad para el receptor IL-4 humano
|
US7732195B2
(en)
|
2006-11-01 |
2010-06-08 |
Facet Biotech Corporation |
Tethered vectors for cell surface immunoglobulin display
|
RU2448979C2
(ru)
|
2006-12-14 |
2012-04-27 |
Ридженерон Фармасьютикалз, Инк. |
Антитела человека к дельта-подобному лиганду-4 человека
|
GB0700194D0
(en)
|
2007-01-05 |
2007-02-14 |
Univ Edinburgh |
Humanisation of animals
|
WO2008103474A1
(en)
|
2007-02-20 |
2008-08-28 |
Anaptysbio, Inc. |
Methods of generating libraries and uses thereof
|
DK2125889T3
(da)
|
2007-02-21 |
2014-04-14 |
Univ Massachusetts |
Humane antistoffer mod hepatitis c-virus (hcv) og anvendelser deraf
|
KR101540822B1
(ko)
|
2007-03-27 |
2015-07-30 |
씨 레인 바이오테크놀로지스, 엘엘씨 |
항체 대용물 경쇄 서열을 포함하는 구축물 및 라이브러리
|
GB0706628D0
(en)
|
2007-04-04 |
2007-05-16 |
Univ Erasmus |
Germ-line manipulation 1
|
WO2008151081A1
(en)
|
2007-06-01 |
2008-12-11 |
Omt, Inc. |
Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies
|
WO2009013620A2
(en)
|
2007-06-11 |
2009-01-29 |
Erasmus University Medical Center Rotterdam |
Homologous recombination
|
MY147651A
(en)
|
2007-07-31 |
2012-12-31 |
Regeneron Pharma |
Human antibodies to human cd20 and method of using thereof
|
KR101709488B1
(ko)
|
2007-08-10 |
2017-02-24 |
리제너론 파아마슈티컬스, 인크. |
인간 신경성장인자에 대한 고친화성 인간 항체
|
US9693539B2
(en)
|
2007-08-10 |
2017-07-04 |
E. R. Squibb & Sons, L.L.C. |
HCO32 and HCO27 and related examples
|
EP2592147A1
(en)
|
2007-10-12 |
2013-05-15 |
F. Hoffmann-La Roche AG |
Protein expression from multiple nucleic acids
|
KR20100103810A
(ko)
|
2007-12-10 |
2010-09-28 |
알리바 바이오파마수티컬스, 아이엔씨. |
동종 재조합에 의한 표적화된 영역의 순차적인 치환 방법
|
US8227577B2
(en)
|
2007-12-21 |
2012-07-24 |
Hoffman-La Roche Inc. |
Bivalent, bispecific antibodies
|
WO2009118524A2
(en)
|
2008-03-26 |
2009-10-01 |
Iti Scotland Limited |
Efficient insertion of dna into embryonic stem cells
|
EP2271758B1
(en)
|
2008-04-14 |
2018-09-12 |
Innovative Targeting Solutions Inc. |
Sequence diversity generation in immunoglobulins
|
US20110123527A1
(en)
|
2008-05-23 |
2011-05-26 |
Hiroaki Shizuya |
Method of generating single vl domain antibodies in transgenic animals
|
DK2147594T3
(da)
|
2008-06-27 |
2014-02-10 |
Merus B V |
Antistofproducerende ikke-humane pattedyr
|
DK2346994T3
(da)
|
2008-09-30 |
2022-02-28 |
Ablexis Llc |
Knock-in-mus til fremstilling af kimære antistoffer
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
CN102292445A
(zh)
|
2008-12-18 |
2011-12-21 |
伊拉兹马斯大学鹿特丹医学中心 |
表达人源化抗体的非人转基因动物及其用途
|
EP2394159B1
(en)
|
2009-02-04 |
2018-09-26 |
Molecular Innovations |
Assays for detecting prorenin, and antibodies used therein
|
US20110305692A1
(en)
|
2009-02-24 |
2011-12-15 |
Glaxo Group Limited |
Antigen-binding contructs
|
GB0905023D0
(en)
|
2009-03-24 |
2009-05-06 |
Univ Erasmus Medical Ct |
Binding molecules
|
US9683226B2
(en)
|
2009-04-03 |
2017-06-20 |
Medical Research Council |
Mutants of activation-induced cytidine deaminase (AID) and methods of use
|
CA2764729C
(en)
|
2009-06-26 |
2019-04-02 |
Sea Lane Biotechnologies, Llc |
Expression of surrogate light chains
|
PL3241435T3
(pl)
|
2009-07-08 |
2021-12-13 |
Kymab Limited |
Modele zwierzęce i cząsteczki terapeutyczne
|
US9445581B2
(en)
|
2012-03-28 |
2016-09-20 |
Kymab Limited |
Animal models and therapeutic molecules
|
EP2454283B1
(en)
|
2009-07-15 |
2018-03-14 |
AIMM Therapeutics B.V. |
Means and methods for producing high affinity antibodies
|
JO3182B1
(ar)
|
2009-07-29 |
2018-03-08 |
Regeneron Pharma |
مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
|
US8592644B2
(en)
|
2009-08-13 |
2013-11-26 |
Crystal Bioscience Inc. |
Transgenic animal for production of antibodies having minimal CDRS
|
US8580714B2
(en)
*
|
2009-10-14 |
2013-11-12 |
Janssen Biotech, Inc. |
Methods of affinity maturing antibodies
|
US20120251552A1
(en)
|
2009-11-05 |
2012-10-04 |
Anaptysbio, Inc. |
Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation
|
JP5796846B2
(ja)
|
2009-11-17 |
2015-10-21 |
エスエービー エルエルシー |
ヒト人工染色体ベクター
|
US20120269830A1
(en)
|
2009-12-07 |
2012-10-25 |
Lawrence Horowitz |
Conjugates with improved pharmacokinetic properties
|
EP2954779B1
(en)
|
2009-12-10 |
2019-02-06 |
Regeneron Pharmaceuticals, Inc. |
Mice that make heavy chain antibodies
|
BR112012019887B1
(pt)
|
2010-02-08 |
2021-06-08 |
Regeneron Pharmaceuticals, Inc |
método para fabricação de anticorpo e método para selecionar uma sequência de ácido nucleico da região variável da cadeia pesada humana para produzir um anticorpo
|
US20120021409A1
(en)
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
EP2571512B1
(en)
|
2010-05-17 |
2017-08-23 |
Sangamo BioSciences, Inc. |
Novel dna-binding proteins and uses thereof
|
CN103228130B
(zh)
*
|
2010-06-17 |
2016-03-16 |
科马布有限公司 |
动物模型及治疗分子
|
EP3205726A1
(en)
|
2010-06-22 |
2017-08-16 |
Regeneron Pharmaceuticals, Inc. |
Mice with humanised lambda variable gene segments
|
WO2012009568A2
(en)
*
|
2010-07-16 |
2012-01-19 |
Adimab, Llc |
Antibody libraries
|
AU2011285919C1
(en)
|
2010-08-02 |
2015-09-17 |
Regeneron Pharmaceuticals, Inc. |
Mice that make binding proteins comprising VL domains
|
ES2537207T3
(es)
|
2010-08-16 |
2015-06-03 |
Novimmune S.A. |
Métodos para la generación de anticuerpos multiespecíficos y multivalentes
|
JO3375B1
(ar)
|
2010-11-08 |
2019-03-13 |
Regeneron Pharma |
أجسام مضادة بشرية للجين a1 الشبيه بعامل النخر الورمي (tl1a)
|
CN103261230A
(zh)
|
2010-12-22 |
2013-08-21 |
霍夫曼-拉罗奇有限公司 |
抗pcsk9抗体及使用方法
|
SG10201913160QA
(en)
|
2011-02-25 |
2020-03-30 |
Regeneron Pharma |
Adam6 mice
|
LT3572517T
(lt)
|
2011-08-05 |
2021-04-26 |
Regeneron Pharmaceuticals, Inc. |
Humanizuotos universalios lengvosios grandinės pelės
|
EP3128009B1
(en)
|
2011-09-19 |
2020-07-29 |
Kymab Limited |
Antibodies, variable domains & chains tailored for human use
|
EP2758534B1
(en)
*
|
2011-09-19 |
2020-04-29 |
Kymab Limited |
Animals, repertoires & methods for the production of human antibodies
|
WO2013045916A1
(en)
|
2011-09-26 |
2013-04-04 |
Kymab Limited |
Chimaeric surrogate light chains (slc) comprising human vpreb
|
DK2627773T3
(en)
|
2011-10-17 |
2017-10-02 |
Regeneron Pharma |
MOUSE WITH LIMITED IMMUNOGLOBULIN HEAVY CHAIN
|
US20130102031A1
(en)
|
2011-10-25 |
2013-04-25 |
Anaptysbio, Inc. |
Use of somatic hypermutation to create insertion and deletion mutations in vitro
|
GB2496375A
(en)
|
2011-10-28 |
2013-05-15 |
Kymab Ltd |
A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
|
US20180295821A1
(en)
|
2011-12-02 |
2018-10-18 |
Kymab Limited |
Transgenic Animals
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
KR101924805B1
(ko)
|
2011-12-20 |
2018-12-04 |
리제너론 파마슈티칼스 인코포레이티드 |
인간화 경쇄 마우스
|
ES2870703T3
(es)
|
2012-02-01 |
2021-10-27 |
Regeneron Pharma |
Roedores humanizados que expresan cadenas pesadas que contienen dominios VL
|
WO2013130981A1
(en)
|
2012-03-02 |
2013-09-06 |
Regeneron Pharmaceuticals, Inc. |
Human antibodies to clostridium difficile toxins
|
CN104244709B
(zh)
*
|
2012-03-06 |
2017-03-08 |
瑞泽恩制药公司 |
共同轻链小鼠
|
JP2015512245A
(ja)
|
2012-03-16 |
2015-04-27 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
pH依存性の結合特徴を有する抗原結合タンパク質を産生するマウス
|
US10251377B2
(en)
|
2012-03-28 |
2019-04-09 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
|
EP2831245A1
(en)
|
2012-03-28 |
2015-02-04 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class - switched, fully human, antibodies
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
JO3820B1
(ar)
|
2012-05-03 |
2021-01-31 |
Regeneron Pharma |
أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
|
RS59199B1
(sr)
|
2012-05-25 |
2019-10-31 |
Univ California |
Metode i jedinjenja za rnk-upravljanu ciljanu dnk modifikaciju i za rnk- upravljanu modulaciju transkripta
|
HUE047266T2
(hu)
|
2012-06-12 |
2020-04-28 |
Regeneron Pharma |
Korlátozott immunglobulin nehézlánc lókuszokkal rendelkezõ, humanizált, nem humán élõlények
|
US8962913B2
(en)
|
2012-06-18 |
2015-02-24 |
Regeneron Pharmaceuticals, Inc. |
Humanized IL-7 rodents
|
IL239317B
(en)
|
2012-12-12 |
2022-07-01 |
Broad Inst Inc |
Providing, engineering and optimizing systems, methods and compositions for sequence manipulation and therapeutic applications
|
SG11201505383UA
(en)
|
2013-02-20 |
2015-08-28 |
Regeneron Pharma |
Non-human animals with modified immunoglobulin heavy chain sequences
|
US10993420B2
(en)
|
2013-03-15 |
2021-05-04 |
Erasmus University Medical Center |
Production of heavy chain only antibodies in transgenic mammals
|
US9788534B2
(en)
|
2013-03-18 |
2017-10-17 |
Kymab Limited |
Animal models and therapeutic molecules
|
US20150033372A1
(en)
|
2013-05-01 |
2015-01-29 |
Kymab Limited |
Human VpreB & Chimaeric Surrogate Light Chains in Transgenic Non-Human Vertebrates
|
US9783618B2
(en)
|
2013-05-01 |
2017-10-10 |
Kymab Limited |
Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
|
US11707056B2
(en)
|
2013-05-02 |
2023-07-25 |
Kymab Limited |
Animals, repertoires and methods
|
US9783593B2
(en)
|
2013-05-02 |
2017-10-10 |
Kymab Limited |
Antibodies, variable domains and chains tailored for human use
|
US20140331339A1
(en)
|
2013-05-03 |
2014-11-06 |
Kymab Limited |
Transgenic Non-Human Assay Vertebrates, Assays and Kits
|
US20140331344A1
(en)
|
2013-05-03 |
2014-11-06 |
Kymab Ltd. |
Transgenic Animals
|
TW201546284A
(zh)
|
2013-10-01 |
2015-12-16 |
Kymab Ltd |
動物模式及治療分子
|
GB201710984D0
(en)
|
2017-07-07 |
2017-08-23 |
Kymab Ltd |
Cells, vertebrates, populations & methods
|